Edition:
United Kingdom

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

26.20USD
17 Aug 2018
Change (% chg)

$-0.10 (-0.38%)
Prev Close
$26.30
Open
$26.15
Day's High
$26.40
Day's Low
$26.05
Volume
43,522
Avg. Vol
72,145
52-wk High
$37.45
52-wk Low
$22.40

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.97 December 20 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 9 9 9 9
(3) HOLD 0 0 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.90 1.90 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 8 0.37 0.70 0.00 0.09
Quarter Ending Dec-18 8 0.35 0.73 0.00 0.09
Year Ending Dec-18 9 1.54 2.28 0.88 0.32
Year Ending Dec-19 9 1.59 4.00 0.00 16.11
Earnings (per share)
Quarter Ending Sep-18 6 -0.97 -0.89 -1.03 -0.82
Quarter Ending Dec-18 6 -1.00 -0.92 -1.04 -0.84
Year Ending Dec-18 6 -3.80 -3.25 -3.99 -3.51
Year Ending Dec-19 6 -3.94 -3.71 -4.26 -3.20

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.51 0.69 0.17 33.46
Quarter Ending Mar-18 5.07 0.19 4.87 96.19
Quarter Ending Dec-17 0.08 0.04 0.04 50.67
Quarter Ending Sep-17 0.05 0.08 0.03 50.00
Quarter Ending Jun-17 0.05 0.08 0.03 50.00
Earnings (per share)
Quarter Ending Jun-18 -0.94 -0.94 0.00 -0.35
Quarter Ending Mar-18 -0.71 -0.97 0.26 -36.20
Quarter Ending Dec-17 -0.97 -1.14 0.17 -17.18
Quarter Ending Sep-17 -0.93 -1.01 0.08 -8.14
Quarter Ending Jun-17 -0.94 -0.90 0.04 -4.66

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.37 0.37 0.64 0.58 0.09
Quarter Ending Dec-18 0.35 0.35 0.88 0.80 0.09
Year Ending Dec-18 1.54 1.54 2.00 1.84 0.32
Year Ending Dec-19 1.59 1.59 2.98 2.72 16.11
Earnings (per share)
Quarter Ending Sep-18 -0.97 -0.97 -0.96 -0.95 -0.82
Quarter Ending Dec-18 -1.00 -1.00 -0.96 -0.95 -0.84
Year Ending Dec-18 -3.80 -3.80 -3.74 -3.75 -3.51
Year Ending Dec-19 -3.94 -3.94 -3.78 -3.83 -3.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 1 1
Quarter Ending Dec-18 0 0 1 3
Year Ending Dec-18 0 0 6 1
Year Ending Dec-19 0 0 0 1
Earnings
Quarter Ending Sep-18 0 0 2 3
Quarter Ending Dec-18 0 0 2 4
Year Ending Dec-18 0 0 3 2
Year Ending Dec-19 0 0 2 4